Watchlist Price Alert

Alexion Pharmaceuticals I... (ALXN)

NASDAQ: ALXN · Real-Time Price · USD

182.50

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Alexion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	603.4M	2.4B	77.6M	443.3M	399M
Depreciation & Amortization	329.4M	376.8M	405.3M	496.7M	396M
Stock-Based Compensation	281.1M	237M	203M	243.1M	192M
Other Working Capital	4.21B	3.88B	2.21B	2B	1.75B
Other Non-Cash Items	2.11B	-201.4M	141.4M	148.9M	131M
Deferred Income Tax	-283.4M	-455.4M	32.9M	-45.9M	104M
Change in Working Capital	-33.8M	-276.4M	-434.2M	-170.5M	-136M
Operating Cash Flow	3B	2.08B	426M	1.12B	1.09B
Capital Expenditures	-106.7M	-170.7M	-213M	-357.3M	-333M
Cash Acquisitions	-2.11B	114.7M	n/a	n/a	n/a
Purchase of Investments	-77.2M	-171.1M	-805.1M	-1.66B	-675M
Sales Maturities Of Investments	196.3M	236.9M	1.49B	1.1B	722M
Other Investing Acitivies	n/a	-100K	2.8M	100K	-1M
Investing Cash Flow	-2.1B	9.7M	470.5M	-918.3M	-287M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-510.8M	-416M	-85M	-463.6M	-430M
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-611.9M	-739.1M	-102.4M	-596.6M	-836M
Financial Cash Flow	-611.9M	-739.1M	-102.4M	-596.6M	-836M
Net Cash Flow	311M	1.36B	782.9M	-381.6M	-44M
Free Cash Flow	2.9B	1.91B	213M	758.3M	753M